Optos Celebrates Milestones: 25,000 Devices Installed Globally and Extensive Clinical Publications Achieved

Optos announced a dual milestone achievement of over 25,000 devices installed worldwide, and the collection of 2,500 clinical and peer-reviewed studies spanning 235 disease states, acccording to a company news release.

"This remarkable double milestone reflects the unwavering commitment that Optos has had to innovation and excellence in providing the best and clinically-relevant technology available, since our inception. The ongoing growth and recognition of the robust body of clinical research efforts underscores the dedication of our team to continue improving patient outcomes and driving development in ophthalmic care,” said Chief Executive Officer Robert Kennedy. "We extend our sincerest gratitude to our customers for their continued trust and support. Their feedback and partnership are invaluable as we strive to make retinal imaging more patient-friendly and accessible while empowering clinicians to deliver exceptional care."

Optos, a subsidiary of Nikon, has a total of nine imaging modalities available across all device platforms, including the recent addition of optomap color rgb, natural color and optomap blue fundus autofluorescence imaging modalities. For more information, visit optos.com.